Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
HRB Centre for Diet and Health Research, School of Public Health, Physiotherapy, and Sports Science, University College Dublin, Dublin, Republic of Ireland.
Int J Obes (Lond). 2020 Jul;44(7):1508-1520. doi: 10.1038/s41366-020-0572-0. Epub 2020 Apr 22.
In animal studies early life antibiotic exposure causes metabolic abnormalities including obesity through microbiota disruption, but evidence from human studies is scarce. We examined involvement of gut microbiota in the associations between infant antibiotic exposure and childhood adiposity.
Infant antibiotic exposure in the first year of life was ascertained using parental reports during interviewer-administered questionnaires. Primary outcomes were childhood obesity [body mass index (BMI) z-score > 95th percentile] and adiposity [abdominal circumference (AC) and skinfold (triceps + subscapular (SST)) measurements] determined from ages 15-60 months. At age 24 months, when the gut microbiota are more stable, stool samples (n = 392) were collected for the gut microbiota profiling using co-abundancy networks. Associations of antibiotic exposure with obesity and adiposity (n = 1016) were assessed using multiple logistic and linear mixed effects regressions. Key bacteria associated with antibiotics exposure were identified by partial redundancy analysis and multivariate association with linear models.
Antibiotic exposure was reported in 38% of study infants. In a fully adjusted model, a higher odds of obesity from 15-60 months of age was observed for any antibiotic exposure [OR(95% CI) = 1.45(1.001, 2.14)] and exposure to ≥3 courses of antibiotics [2.78(1.12, 6.87)]. For continuous adiposity indicators, any antibiotic exposure was associated with higher BMI z-score in boys [β = 0.15(0.01, 0.28)] but not girls [β = -0.04(-0.19, 0.11)] (P interaction = 0.026). Similarly, exposure to ≥3 courses of antibiotics was associated with higher AC in boys [1.15(0.05, 2.26) cm] but not girls [0.57(-1.32, 2.45) cm] (P interaction not significant). Repeated exposure to antibiotics was associated with a significant reduction (FDR-corrected P values < 0.05) in a microbial co-abundant group (CAG) represented by Eubacterium hallii, whose proportion was negatively correlated with childhood adiposity. Meanwhile, a CAG represented by Tyzzerella 4 was positively correlated with the repeated use of antibiotics and childhood adiposity.
Infant antibiotic exposure was associated with disruption of the gut microbiota and the higher risks of childhood obesity and increased adiposity.
动物研究表明,早期生活中抗生素的暴露会通过破坏微生物群导致代谢异常,包括肥胖,但来自人类研究的证据很少。我们研究了肠道微生物群在婴儿抗生素暴露与儿童肥胖之间的关联中的作用。
在面对面的问卷调查中,通过父母报告来确定婴儿在生命的第一年中抗生素的暴露情况。主要结果是在 15-60 个月时通过肥胖[体重指数(BMI)z 分数>第 95 百分位数]和肥胖度[腹部周长(AC)和皮褶(三头肌+肩胛下(SST)]来确定儿童肥胖[肥胖(BMI z 分数>第 95 百分位数)]和肥胖度(AC 和 SST 测量)。在 24 个月时,当肠道微生物群更稳定时,收集了 392 份粪便样本,用于使用共同丰度网络进行肠道微生物群分析。使用多元逻辑和线性混合效应回归评估抗生素暴露与肥胖和肥胖度(n=1016)的关联。通过部分冗余分析和多元关联线性模型确定与抗生素暴露相关的关键细菌。
研究中的婴儿中有 38%报告了抗生素暴露。在完全调整的模型中,与任何抗生素暴露[OR(95%CI)=1.45(1.001,2.14)]和暴露于≥3 疗程的抗生素[2.78(1.12,6.87)]相关,儿童肥胖的几率更高(OR)。对于连续的肥胖指标,任何抗生素暴露与男孩的 BMI z 评分更高相关[β=0.15(0.01,0.28)],但与女孩无关[β=-0.04(-0.19,0.11)](P 交互=0.026)。同样,暴露于≥3 疗程的抗生素与男孩的 AC 更高相关[1.15(0.05,2.26)cm],但与女孩无关[0.57(-1.32,2.45)cm](P 交互无显著意义)。抗生素的重复暴露与一个由 Eubacterium hallii 代表的微生物共同丰富群(CAG)显著减少(经 FDR 校正的 P 值<0.05)有关,其比例与儿童肥胖呈负相关。同时,由 Tyzzerella 4 代表的 CAG 与抗生素的重复使用和儿童肥胖呈正相关。
婴儿抗生素的暴露与肠道微生物群的破坏以及儿童肥胖和肥胖度增加的更高风险有关。